No definition available.
Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced
PHLEBI_THROMBOP_SUPERF_VESSE_LOWER_EXTREMITI
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
104 |
4. Check minimum number of eventsNone |
104 |
5. Include endpointsNone |
104 |
6. Filter based on genotype QC (FinnGen only) |
104 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced
based on the number of shared cases.
Similar with more cases:
- Phlebitis and thrombophlebitis (not including DVT)
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 104 | 68 | 36 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 54.24 | 53.57 | 55.52 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 98
- Matched controls
- 980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
+∞
122.1
98
16
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
6.4
11.0
31
66
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
11.2
9.2
17
18
B01AA03
ATC
warfarin; systemic
3.9
8.5
43
164
PHD99
NOMESCO Finland
Resection of other vein
6.7
7.9
20
36
PHD76
NOMESCO Finland
Resection of long saphenous vein
7.4
7.0
16
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
187
2.31
3.71
1.5
1.8
1.7
1.4
mg/l
0.15
25
157
42
255
2.09
3.17
4.3
3.1
1.1
0.4
e6/l
0.49
36
188
50
331
1.98
2.93
4.9
3.2
—
—
—
0
0
26
137
2.20
2.78
3.4
2.8
4.0
4.3
e6/l
0.03
18
73
26
149
1.99
2.21
3.8
2.6
1.0
1.4
e6/l
0.45
18
82
17
84
2.22
2.10
2.6
5.3
207.8
259.4
u/l
1.99
17
77
31
199
1.79
1.86
2.6
2.1
2.5
3.1
mg/l
0.81
25
170
64
761
0.59
1.79
3.7
4.2
1.2
1.3
mmol/l
0.45
59
672
68
794
0.59
1.73
4.2
4.6
1.5
1.5
mmol/l
0.29
62
710
27
178
1.70
1.46
4.9
3.4
3906.0
100.5
ng/l
0.47
22
154
70
799
0.62
1.39
4.4
4.7
4.5
4.6
mmol/l
0.41
65
721
6
24
2.59
1.32
1.2
1.3
—
—
—
0
0
6
24
2.59
1.32
1.2
1.3
—
—
—
0
0
5
18
2.86
1.30
1.0
1.3
—
—
—
0
0
67
768
0.64
1.29
6.6
6.3
40.9
40.8
mmol/mol
0.02
62
707
5
19
2.71
1.23
1.6
2.1
—
—
—
0
0
0
34
0.00
1.18
0.0
2.2
—
—
—
0
0
13
74
1.86
1.13
1.6
2.5
0.2
0.2
g/l
0.07
13
67
72
804
0.66
1.08
5.3
5.0
5.9
6.0
mmol/l
0.26
66
727
15
92
1.74
1.04
3.7
4.2
—
—
—
0
0
17
110
1.65
0.98
1.5
1.8
—
—
—
0
0
9
51
1.84
0.97
3.4
7.7
25.7
25.8
mmol/l
—
9
51
0
32
0.00
0.97
0.0
2.1
—
—
—
0
0
79
860
0.66
0.94
10.9
10.8
24.4
23.8
u/l
0.17
79
826
30
229
1.44
0.84
1.4
1.6
1.1
1.3
mmol/l
0.79
25
183
6
32
1.93
0.83
1.2
1.2
—
—
—
0
0
6
32
1.93
0.83
1.0
1.2
—
—
—
0
0
16
109
1.55
0.76
1.6
1.8
—
—
—
0
0
7
41
1.76
0.71
1.0
1.2
—
—
—
0
0
45
379
1.33
0.69
2.6
1.9
90.0
95.4
pmol/l
0.28
24
184
80
856
0.72
0.66
24.1
18.9
75.8
77.7
umol/l
0.35
80
856
80
854
0.73
0.62
24.7
18.8
3.9
4.0
mmol/l
0.67
80
830
8
52
1.58
0.61
1.6
1.4
—
—
—
0
0
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
80
851
0.74
0.56
24.3
18.8
140.0
139.7
mmol/l
0.52
80
826
13
94
1.44
0.48
1.2
1.4
—
—
—
0
0
47
416
1.24
0.45
6.0
5.7
0.0
0.0
estimate
—
9
72
8
55
1.49
0.44
1.1
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
47
421
1.21
0.39
4.5
4.3
0.0
0.0
estimate
—
9
73
46
412
1.21
0.38
4.6
4.3
0.0
0.0
estimate
—
9
77
72
760
0.83
0.33
20.9
15.5
75.8
74.7
ml/min/173m2
0.17
59
619
5
41
1.23
0.22
5.6
2.6
3.2
3.1
g/l
—
5
35
8
104
0.75
0.22
1.8
1.3
—
—
—
0
0
48
447
1.14
0.22
5.7
6.8
1.2
1.2
mmol/l
0.08
42
375
20
228
0.85
0.21
5.6
4.7
0.0
0.0
estimate
—
9
75
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
4.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
51
478
1.13
0.21
6.8
9.3
4.2
4.2
e9/l
0.07
36
421
0
13
0.00
0.21
0.0
3.2
—
138.8
—
0
13
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
16
137
1.20
0.20
2.2
1.7
35.8
29.9
s
0.80
16
130
36
390
0.88
0.20
3.4
3.9
—
—
—
0
0
79
816
0.87
0.19
21.9
16.0
23.3
25.8
mg/l
0.39
73
649
5
66
0.75
0.17
7.0
5.3
23.2
24.7
mmol/l
—
5
61
13
111
1.20
0.16
3.5
7.1
4.8
5.1
kpa
0.70
13
104
13
111
1.20
0.16
3.5
7.1
13.6
11.7
kpa
0.34
13
104
10
83
1.23
0.16
1.3
1.9
342.4
365.8
nmol/l
—
10
74
17
152
1.14
0.13
1.5
1.9
—
—
—
0
0
40
420
0.92
0.11
2.4
2.5
—
—
—
0
0
33
311
1.09
0.11
2.7
3.3
2.4
2.3
mmol/l
0.02
28
279
11
125
0.87
0.11
2.6
3.0
0.8
1.0
ug/l
—
6
90
5
43
1.17
0.10
5.6
2.4
14.8
10.0
g/l
—
5
38
5
44
1.14
0.10
5.6
2.5
7.6
7.7
g/l
—
5
36
5
44
1.14
0.10
5.6
2.5
3.5
3.7
g/l
—
5
34
5
44
1.14
0.10
5.6
2.5
—
—
—
0
0
74
757
0.92
0.09
6.1
4.9
1.8
1.9
mu/l
0.69
69
671
7
67
1.05
0.08
1.7
1.6
—
—
—
0
0
63
615
1.06
0.07
4.4
4.1
15.1
15.0
pmol/l
0.10
58
543
33
318
1.06
0.05
4.5
4.6
—
—
—
0
0
20
211
0.94
0.05
2.4
2.4
—
—
—
0
0
29
280
1.05
0.03
1.8
2.1
118.0
202.3
u/l
2.15
29
265
35
344
1.03
0.00
4.9
4.2
24.7
49.9
ng/l
1.20
26
266
36
363
0.99
0.00
3.1
2.3
77.6
79.9
nmol/l
0.18
31
321
17
166
1.03
0.00
2.9
4.2
28.4
21.9
%
—
7
82
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
45.3
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
8.4
—
224.0
—
0
5
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: PHLEBI_THROMBOP_SUPERF_VESSE_LOWER_EXTREMITI – Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced
GWS hits: -
This endpoint is excluded (not available in FinRegistry).